GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Kenvue Inc.
Kenvue, home to brands like Tylenol, Listerine, and Band-Aid, was spun off from Johnson & Johnson. Its shares offer investors stability and predictability based on consumers' everyday needs for health and hygiene products.
Share prices of companies in the market segment - Pharma other
Kenvue, spun off from Johnson & Johnson, is a pure-play consumer health business, owning the Tylenol, Listerine, and Band-Aid brands. We classify it as part of the Pharmaceutical Other sector, and the chart below reflects the overall performance of this segment.
Broad Market Index - GURU.Markets
Kenvue is a global consumer health company spun off from Johnson & Johnson, owning the Listerine, Band-Aid, and Tylenol brands. It is a component of the GURU.Markets index. The chart below represents the market. See how Kenvue shares compare to the consumer health sector.
Change in the price of a company, segment, and market as a whole per day
KVUE - Daily change in the company's share price Kenvue Inc.
Kenvue, spun off from Johnson & Johnson, is a giant in the consumer health sector (brands include Listerine, Band-Aid, and Tylenol). Its daily price change reflects the sector's inherent volatility. This metric is important for analytical formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma other
Kenvue Inc. is a consumer health care giant spun off from Johnson & Johnson. This chart shows the sector's average daily volatility. Comparing it to KVUE's performance helps us understand how its portfolio of well-known brands (Tylenol, Listerine) makes its business defensive.
Daily change in the price of a broad market stock, index - GURU.Markets
Kenvue, a spinoff from Johnson & Johnson, is a giant in consumer health products (Listerine, Band-Aid, Tylenol). This sector is considered defensive. The chart below shows the overall market volatility, which often makes Kenvue's performance appear calmer.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Kenvue Inc.
Kenvue, a spinoff from Johnson & Johnson, is now a giant in the over-the-counter consumer health products space, owning brands such as Tylenol and Listerine. Its year-over-year growth reflects stable demand for its products, which is largely unaffected by economic cycles.
Annual dynamics of market capitalization of the market segment - Pharma other
Kenvue Inc., spun off from Johnson & Johnson, is home to well-known brands like Tylenol, Listerine, and Band-Aid. As a pure-play consumer health company, its success depends on the strength of its brands and customer loyalty. The chart below shows how this stable business is valued by the market.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Kenvue is a consumer healthcare giant spun off from Johnson & Johnson, owning brands such as Tylenol and Listerine. Its business is completely non-cyclical, as demand for its products is constant. Kenvue shares are a classic defensive asset, offering stability during periods of market turbulence.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Kenvue Inc.
The market capitalization dynamics of Kenvue Inc. (KVUE) by Perf_Month_Co reflects medium-term sales expectations for consumer health products (Tylenol, Listerine). Monthly fluctuations in the chart are driven by the success of its brands following the spinoff from J&J, advertising campaigns, and cost inflation management.
Monthly dynamics of market capitalization of the market segment - Pharma other
This chart reflects the dynamics of the consumer health sector. For Kenvue, spun off from Johnson & Johnson, it provides context. It shows how its portfolio of well-known over-the-counter brands (Tylenol, Listerine) is delivering steady, albeit slow, growth.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Kenvue Inc., spun off from Johnson & Johnson, is home to well-known consumer brands such as Tylenol, Listerine, and Neutrogena. Demand for its products is stable and unaffected by the economy. A broad market chart allows you to assess how the defensive nature of its business and the strength of its brands make its shares resilient to general economic downturns.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Kenvue Inc.
Shares of Kenvue, Johnson & Johnson's consumer division (brands: Tylenol, Listerine, Band-Aid), reflect consumer spending on a weekly basis. Price movements reflect seasonal flu seasons (demand for cold medications) and loyalty to well-known brands in pharmacies and stores.
Weekly dynamics of market capitalization of the market segment - Pharma other
The over-the-counter consumer health care sector is a story of trusted brands. Weekly trends across the industry reflect everyday purchases and seasonal ailments. The chart illustrates this stable backdrop, with Kenvue, a new giant, vying for shelf space.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Kenvue is a consumer health giant (Listerine, Tylenol, Neutrogena), spun off from Johnson & Johnson. Demand for its products is stable. The chart below will help you determine whether Kenvue shares have "defensive" properties: do they demonstrate resilience during general market turbulence?
Market capitalization of the company, segment and market as a whole
KVUE - Market capitalization of the company Kenvue Inc.
Kenvue's market capitalization chart tells the story of the birth of a new consumer health giant following its spinoff from Johnson & Johnson. Its dynamics reflect the strength of century-old brands like Tylenol, Listerine, and Band-Aid. The trajectory is the market's attempt to assess how this focused company will fare independently in a stable yet competitive market.
KVUE - Share of the company's market capitalization Kenvue Inc. within the market segment - Pharma other
Kenvue is a consumer healthcare giant spun out of Johnson & Johnson. With brands like Listerine, Band-Aid, and Tylenol, the company holds dominant market share across many categories. The chart shows the weight of this new but mature player, whose strength lies in its portfolio of world-renowned and trusted brands.
Market capitalization of the market segment - Pharma other
Kenvue is a consumer health giant spun off from Johnson & Johnson and owns brands such as Listerine, Band-Aid, and Tylenol. The chart below shows the market capitalization of this stable sector. Its performance reflects the strength of its iconic brands and the continued demand for over-the-counter medications and personal care products.
Market capitalization of all companies included in a broad market index - GURU.Markets
Kenvue is a consumer healthcare giant spun off from Johnson & Johnson, owning brands such as Tylenol, Listerine, and Band-Aid. Its market capitalization reflects the trust and habits of consumers worldwide. Its weight on the overall chart reflects the strength of its everyday brands, found in every medicine cabinet.
Book value capitalization of the company, segment and market as a whole
KVUE - Book value capitalization of the company Kenvue Inc.
Kenvue, spun off from Johnson & Johnson, has a balance sheet comprised of its consumer health products manufacturing plants (Listerine, Tylenol) and world-renowned brands, backed by capital. This is a real, tangible foundation, sitting on the shelf in every pharmacy. What does it look like after the spinoff? The chart below shows its starting position and performance.
KVUE - Share of the company's book capitalization Kenvue Inc. within the market segment - Pharma other
Kenvue, the former consumer division of Johnson & Johnson, owns factories that produce brands like Tylenol and Band-Aid. The chart shows the share of this manufacturing capacity in the sector, reflecting the physical scale behind the health products in every medicine cabinet.
Market segment balance sheet capitalization - Pharma other
Manufacturing consumer health products like Kenvue's is capital-intensive. Owning factories that produce brands like Tylenol makes it a heavyweight among the assets of the overall consumer goods sector.
Book value of all companies included in the broad market index - GURU.Markets
Kenvue's assets, spun off from Johnson & Johnson, comprise a global network of factories producing well-known brands like Tylenol, Listerine, and Neutrogena. The book value reflects the physical scale of production of health products found in virtually every home. The chart shows the weight of this emerging, yet mature, consumer giant.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Kenvue Inc.
Kenvue, the owner of the Tylenol and Listerine brands spun off from J&J, is valued at a premium to its manufacturing plants. Investors are paying for its portfolio of world-renowned, trusted brands, which ensures stable sales and cash flow.
Market to book capitalization ratio in a market segment - Pharma other
Kenvue is a consumer healthcare giant spun off from Johnson & Johnson, owning the Listerine, Band-Aid, and Tylenol brands. Its core value lies in its portfolio of these world-renowned brands. The chart shows the premium the market pays for consumer trust and stable demand.
Market to book capitalization ratio for the market as a whole
Kenvue is a consumer giant spun off from Johnson & Johnson, owning brands such as Tylenol, Listerine, and Band-Aid. The company's value lies in its portfolio of brands that have endured for generations. This metric reflects how the market values โโthis collection of timeless brands that generate stable cash flow.
Debts of the company, segment and market as a whole
KVUE - Company debts Kenvue Inc.
Kenvue, a company with a portfolio of well-known consumer brands (Listerine, Tylenol), was spun off from Johnson & Johnson with significant debt. Its financial strategy is focused on using stable cash flows to service this debt and pay dividends. This chart shows the financial profile of this new, yet mature, player in the market.
Market segment debts - Pharma other
Kenvue is a spinoff from Johnson & Johnson, which owns well-known consumer health brands such as Tylenol, Listerine, and Band-Aid. This business generates stable cash flows. The chart shows Kenvue's debt level when it launched its independent operations and its strategy for servicing it, investing in brands, and paying dividends.
Market debt in general
Kenvue, a company spinning off Johnson & Johnson and owning a portfolio of well-known consumer health brands (e.g., Tylenol, Listerine), typically generates stable cash flows. This chart allows you to assess how Kenvue manages the debt acquired during the spinoff and how its financial policies compare to other consumer giants.
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Kenvue Inc.
Kenvue, a spinoff from Johnson & Johnson, owns brands such as Tylenol and Listerine. This chart shows how the newly independent company is shaping its financial structure. It reflects the initial debt level and its management strategy, which is critical for funding marketing and innovation in the highly competitive consumer health products sector.
Market segment debt to market segment book capitalization - Pharma other
Kenvue, a consumer healthcare giant spun off from Johnson & Johnson, owns brands such as Tylenol, Listerine, and Band-Aid. This chart compares the company's debt to the overall market capitalization of the pharmaceutical sector. It shows the company's financial profile after the split and its capital management strategy as an independent player.
Debt to book value of all companies in the market
Kenvue, a manufacturer of over-the-counter medications and health products, operates in the defensive sector. This chart compares the company's debt to the overall market capitalization. It clearly demonstrates how stable the financial position of a consumer goods company is compared to the volatility of the broader market.
P/E of the company, segment and market as a whole
P/E - Kenvue Inc.
Kenvue, a spinoff from Johnson & Johnson, owns a portfolio of well-known consumer brands such as Tylenol, Listerine, and Band-Aid. This chart shows how investors value this stable and predictable business. The valuation reflects the strength of the brands and the continued demand for health products.
P/E of the market segment - Pharma other
Kenvue is a global consumer health company spun off from Johnson & Johnson. Its portfolio includes well-known brands such as Tylenol, Listerine, Neutrogena, and Band-Aid. This chart shows the average valuation for the sector, helping to understand how the market values โโthis portfolio of iconic over-the-counter brands.
P/E of the market as a whole
Kenvue, spun off from Johnson & Johnson, owns a portfolio of well-known consumer health brands such as Tylenol, Listerine, and Band-Aid. This business is considered defensive. Does comparing its valuation to this chart of overall market sentiment confirm this status? Or are inflation and private-label competition challenging it?
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Kenvue Inc.
Kenvue, a Johnson & Johnson spinoff, owns a portfolio of well-known consumer health brands such as Tylenol, Listerine, and Band-Aid. This chart shows how the market views the future stability and profitability of this portfolio of strong, recognizable brands in consumers' everyday lives.
Future (projected) P/E of the market segment - Pharma other
Kenvue is a spinoff from Johnson & Johnson, the parent company of well-known consumer healthcare brands such as Tylenol, Listerine, Band-Aid, and Neutrogena. This chart reflects expectations for Kenvue's future profitability, demonstrating how highly the market values โโits portfolio of recognizable and stable brands that are unaffected by economic cycles.
Future (projected) P/E of the market as a whole
Kenvue, spun off from Johnson & Johnson, owns a portfolio of well-known consumer health brands such as Tylenol, Listerine, and Band-Aid. Their business is characterized by stable demand. This graph of overall expectations shows that essential products remain in demand regardless of economic conditions.
Profit of the company, segment and market as a whole
Company profit Kenvue Inc.
Kenvue is a consumer healthcare giant spun off from Johnson & Johnson, owning brands such as Tylenol, Listerine, and Band-Aid. This chart demonstrates the strength of its portfolio of well-known and proven products. Its stable profitability is driven by customer loyalty and consistent demand for its health products.
Profit of companies in the market segment - Pharma other
Kenvue, a spinoff from Johnson & Johnson, owns a portfolio of well-known consumer health brands such as Listerine, Band-Aid, and Tylenol. This chart shows profitability in the over-the-counter pharmaceuticals sector. The strength and recognition of its brands ensures the company's stable sales and dominant position on store shelves.
Overall market profit
Kenvue, a spinoff from Johnson & Johnson, owns a portfolio of well-known consumer health brands (Listerine, Tylenol, Neutrogena). Demand for its products is generally stable. However, the overall economic situation, reflected in this chart, may influence consumers' willingness to pay for well-known brands over cheaper alternatives.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Kenvue Inc.
Kenvue Inc., a Johnson & Johnson spinoff, owns a portfolio of well-known consumer health brands such as Tylenol, Listerine, and Band-Aid. This chart shows analysts' future earnings expectations, based on the robust demand for these products, which are integral parts of home medicine cabinets worldwide.
Future (predicted) profit of companies in the market segment - Pharma other
Kenvue is a consumer healthcare giant spun off from Johnson & Johnson, with a portfolio of brands including Listerine, Band-Aid, Tylenol, and Neutrogena. The sector's profit projections, shown in the graph, reflect the stable demand for healthcare products. This chart helps assess how Kenvue is leveraging its megabrands to dominate store shelves.
Future (predicted) profit of the market as a whole
Kenvue is a consumer healthcare company spun out of Johnson & Johnson. It owns well-known brands such as Listerine, Band-Aid, and Tylenol. Demand for its products is stable and less dependent on economic cycles, as reflected in this chart, making its shares attractive to conservative investors.
P/S of the company, segment and market as a whole
P/S - Kenvue Inc.
Kenvue, a Johnson & Johnson spinoff, owns a portfolio of well-known consumer brands such as Listerine, Band-Aid, and Tylenol. This chart shows how the market values โโthe revenue from these products. A stable valuation reflects the strength of the brands and the continued demand for health and hygiene products.
P/S market segment - Pharma other
Kenvue is a consumer healthcare giant spun off from Johnson & Johnson. The company owns well-known brands such as Tylenol, Listerine, Band-Aid, and Neutrogena, ensuring stable and predictable revenue. This chart shows the average valuation in the sector, helping to understand how the market values โโKenvue's robust brand portfolio.
P/S of the market as a whole
Kenvue is a consumer healthcare company spun out of Johnson & Johnson. It owns world-renowned brands such as Listerine, Band-Aid, Tylenol, and Neutrogena. This chart provides an opportunity to assess how the market perceives the stable revenue of its strong consumer brand portfolio compared to the market average.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Kenvue Inc.
Kenvue is a consumer health products company spun off from Johnson & Johnson, with brands such as Tylenol, Listerine, and Band-Aid. This chart shows how investors estimate its future stable earnings. The valuation is based on the strength and recognition of its brand portfolio.
Future (projected) P/S of the market segment - Pharma other
Kenvue is a consumer healthcare company spun off from Johnson & Johnson, owning well-known brands such as Listerine, Band-Aid, Tylenol, and Neutrogena. This chart compares the company's estimated future sales with those of other pharmaceutical companies. It shows how investors assess its growth potential based on the strength and recognition of its portfolio.
Future (projected) P/S of the market as a whole
Kenvue, a Johnson & Johnson spinoff, owns a portfolio of well-known consumer healthcare brands such as Tylenol, Listerine, and Band-Aid. Demand for its products is stable and unaffected by economic cycles. Amid the fluctuating expectations shown by this chart, Kenvue demonstrates the resilience inherent in healthcare products.
Sales of the company, segment and market as a whole
Company sales Kenvue Inc.
This chart illustrates the revenue of Kenvue, a company spun off from Johnson & Johnson and holding a portfolio of well-known consumer health brands such as Tylenol, Listerine, and Band-Aid. Revenue is generated from sales of these over-the-counter products. The growth in this metric demonstrates the strength of the brands and the stable demand for everyday health care products.
Sales of companies in the market segment - Pharma other
Kenvue is a consumer healthcare company spun off from Johnson & Johnson. Its portfolio includes world-renowned brands such as Listerine, Tylenol, Neutrogena, and Band-Aid. This chart shows revenue in the consumer pharmaceuticals sector, reflecting the robust demand for trusted over-the-counter medications and personal care products.
Overall market sales
Kenvue Inc. was spun off from Johnson & Johnson and is home to well-known brands like Tylenol, Listerine, and Band-Aid. It's a giant in the consumer health and wellness space. Demand for its products is stable, but rising affluence, reflected in this chart, is allowing consumers to spend more on branded health and personal care products.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Kenvue Inc.
Kenvue, a Johnson & Johnson spinoff, owns a portfolio of well-known consumer health brands such as Tylenol, Listerine, and Band-Aid. This revenue forecast chart reflects consumer spending on health products. This growth is driven by expectations of robust demand for its trusted and recognizable brands.
Future (projected) sales of companies in the market segment - Pharma other
Kenvue is a consumer health company spun off from Johnson & Johnson. It owns world-renowned brands such as Tylenol, Listerine, Band-Aid, and Neutrogena. This chart shows projected revenue for the over-the-counter pharmaceuticals sector, reflecting the robust demand for health and personal care products.
Future (projected) sales of the market as a whole
Kenvue, a spinoff from Johnson & Johnson, owns a portfolio of well-known over-the-counter brands such as Tylenol, Listerine, and Band-Aid. Demand for its products is stable, as they are everyday health products. Projections for consumer spending growth support the company's ability to invest in marketing and maintain its leadership.
Marginality of the company, segment and market as a whole
Company marginality Kenvue Inc.
Kenvue was spun off from Johnson & Johnson and owns a portfolio of well-known consumer health brands such as Tylenol, Listerine, and Band-Aid. This chart demonstrates the stability and profitability of a business built on consumer trust and brand strength. Customer loyalty provides the company with pricing power and predictable revenue.
Market segment marginality - Pharma other
Kenvue is a consumer health products company spun off from Johnson & Johnson. Its portfolio includes well-known brands such as Listerine, Tylenol, and Neutrogena. Profitability depends on the strength of these brands. This chart shows the average profitability in the sector, allowing you to assess how well Kenvue is performing as an independent company.
Market marginality as a whole
Kenvue, a spinoff from Johnson & Johnson, owns well-known brands such as Tylenol, Listerine, and Neutrogena. Demand for its consumer health products is stable and largely unaffected by general economic cycles, as reflected in this chart. The strength of its brands and the everyday nature of its products provide the company with robust cash flow.
Employees in the company, segment and market as a whole
Number of employees in the company Kenvue Inc.
Kenvue is a consumer health giant spun off from Johnson & Johnson. Its portfolio includes world-renowned brands like Tylenol, Listerine, and Band-Aid. This chart shows the vast global team behind the research, production, and marketing of these products, which are found in nearly every home medicine cabinet.
Share of the company's employees Kenvue Inc. within the market segment - Pharma other
Kenvue is a consumer health products company spun out of Johnson & Johnson (Listerine, Tylenol). Managing a portfolio of globally recognized brands is a massive undertaking. This chart illustrates its immediate scale as a new, independent giant, measuring its large share of employment in the consumer health industry.
Number of employees in the market segment - Pharma other
Kenvue was spun off from Johnson & Johnson and encompasses a portfolio of world-renowned consumer brands such as Listerine, Band-Aid, and Tylenol. This chart demonstrates the scale of a business built on products found in nearly every medicine cabinet. It illustrates the stability of demand and the need for a large team to manage the marketing and distribution of these brands.
Number of employees in the market as a whole
Kenvue, home to brands like Tylenol and Band-Aid, is a giant in the consumer health products market. Its vast global workforce reflects the scale and stability of this market, whose products are always in demand.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Kenvue Inc. (KVUE)
Kenvue, spun off from Johnson & Johnson, owns a portfolio of well-known consumer brands (Listerine, Tylenol). This chart reflects a brand-based business. While production and sales require a large staff, the company's primary value lies in intangible assetsโthe recognition and trust consumers place in its products.
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma other
Kenvue (KVUE) is a Johnson & Johnson spinoff that owns a portfolio of consumer brands (Listerine, Tylenol, Neutrogena). Like Haleon, it is a brand-heavy business. This metric, compared to the industry average, reflects how highly the market values โโthe strength of these well-known brands per employee.
Market capitalization per employee (in thousands of dollars) for the overall market
Kenvue is the Johnson & Johnson spinoff of its consumer health and wellness business, with brands such as Tylenol and Listerine. This metric reflects the value of its portfolio of well-known and trusted brands. The market evaluates the Kenvue team's ability to manage these assets and generate stable cash flow in the fast-moving consumer goods sector.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Kenvue Inc. (KVUE)
Kenvue is a consumer health giant spun out of Johnson & Johnson. They own brands like Tylenol, Listerine, and Band-Aid. It's a business built on decades-old, established brands. This chart shows how profitable these brands are. Their high profit per employee is a result of their global reach and high margins.
Profit per employee (in thousands of dollars) in the market segment - Pharma other
Kenvue (KVUE) is a consumer health giant (Tylenol, Listerine), spun off from J&J. This chart shows the benchmark for Pharma (Consumer Goods). The average profit per employee here is a classic CPG model. The benchmark reflects a balance: profit is generated by brand strength and marketing, not just R&D.
Profit per employee (in thousands of dollars) for the market as a whole
Kenvue, a consumer division spun off from Johnson & Johnson, owns brands such as Tylenol, Listerine, and Neutrogena. This chart shows the efficiency of the business, built on decades-old, well-known brands sold in pharmacies and stores worldwide, per employee.
Sales to employees of the company, segment and market as a whole
Sales per company employee Kenvue Inc. (KVUE)
Kenvue, spun off from Johnson & Johnson, is a pure-play consumer healthcare company with brands including Listerine, Band-Aid, and Tylenol. This chart demonstrates the strength of its portfolio. Its high revenue per employee reflects its global brand recognition and the efficiency of its supply chain and marketing.
Sales per employee in the market segment - Pharma other
Kenvue is a consumer health division spun off from Johnson & Johnson (brands Tylenol, Listerine, Neutrogena). Their business encompasses R&D, manufacturing, and, most importantly, brand marketing. This chart shows the average revenue per employee for the sector. It helps assess how effectively Kenvue monetizes its renowned brands.
Sales per employee for the market as a whole
Kenvue, a spinoff from Johnson & Johnson, owns their portfolio of consumer brands: Tylenol, Listerine, and Neutrogena. Their business encompasses brand management, marketing, and distribution. This chart shows how effectively their team monetizes these decades-old and trusted brands.
Short shares by company, segment and market as a whole
Shares shorted by company Kenvue Inc. (KVUE)
Kenvue, a Johnson & Johnson spinoff, owns a portfolio of consumer brands (Tylenol, Listerine, Band-Aid). This chart shows bearish bets. Bears may be concerned about legal risks associated with talc lawsuits or the weak growth momentum typical of large consumer companies.
Shares shorted by market segment - Pharma other
Kenvue is a consumer health giant spun off from Johnson & Johnson. They own brands such as Tylenol, Listerine, Band-Aid, and Neutrogena. This metric reflects bets against the company. Shorts on Kenvue may be due to concerns about lawsuits (such as those related to talc or Tylenol) or, like Haleon, increased competition from cheaper private label retailers.
Shares shorted by the overall market
Kenvue is a consumer health giant spun off from Johnson & Johnson. It owns brands such as Tylenol, Band-Aid, and Listerine. This market pessimism only underscores Kenvue's strength. Its products are basic goods that people buy in any economic climate. This makes Kenvue a classic defensive asset, a safe haven during a market storm.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Kenvue Inc. (KVUE)
Kenvue, spun off from J&J, owns consumer health brands (Tylenol, Band-Aid). It's a defensive sector. An oscillator above 70 may reflect income stability or a flight to "safe" stocks. A level below 30 may reflect concerns about rising costs or lawsuits.
RSI 14 Market Segment - Pharma other
Kenvue (KVUE) is J&J's "consumer" legacy: brands like Tylenol, Listerine, and Band-Aid. It's a defensive but slow-growing business. This indicator shows the "temperature" of the sector. It helps understand: is KVUE oversold due to litigation risks (talc) or is the entire "consumer" sector "cooled"?
RSI 14 for the overall market
Kenvue is a consumer health giant spun off from Johnson & Johnson. It owns Tylenol, Listerine, and Band-Aid. It's a classic "defensive" business. This chart measures the overall level of fear or euphoria in the market. It helps us understand whether KVUE fluctuations are driven by general market panic (when everyone is looking for "safe" stocks) or euphoria, rather than the strength of their brands.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast KVUE (Kenvue Inc.)
Kenvue is a spinoff from Johnson & Johnson, the owner of iconic brands Tylenol, Listerine, Band-Aid, and Neutrogena. It's a consumer health giant. This chart shows analysts' average 12-month forecasts, reflecting their expectations for the strength of these mega-brands and their ability to maintain market share.
The difference between the consensus estimate and the actual stock price KVUE (Kenvue Inc.)
Kenvue (KVUE) is a consumer health giant spun off from Johnson & Johnson. Their portfolio includes brands such as Tylenol, Listerine, Band-Aid, and Neutrogena. This chart shows the valuation of these mega-brands. It shows the gap between the price and the consensus target, reflecting the potential analysts see in their stable business after the separation from J&J.
Analyst consensus forecast for stock prices by market segment - Pharma other
Kenvue is the former consumer division of Johnson & Johnson (J&J), home to iconic brands Tylenol, Listerine, and Band-Aid. This chart shows analysts' overall expectations across the consumer health sector. It reflects whether experts believe brand strength will support price control or whether they expect cost savings.
Analysts' consensus forecast for the overall market share price
Kenvue Inc. is a consumer health giant spun off from Johnson & Johnson. It owns the Listerine, Band-Aid, Tylenol, and Neutrogena brands. It's a classic defense business. This chart reflects the overall market sentiment. For Kenvue, whose demand is consistently stable, general market pessimism often plays into its hands, as investors seek predictability and stable dividends.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Kenvue Inc.
Kenvue is a consumer health giant recently spun off from Johnson & Johnson. Their portfolio is filled with iconic brands (Tylenol, Listerine, Band-Aid). Like Haleon, they are a defensive-demand business. This chart is a comprehensive assessment of the strength of these brands. It measures their ability to maintain market share, increase prices, and operate effectively as a stand-alone public company.
AKIMA Market Segment Index - Pharma other
Kenvue (KVUE) is a consumer health giant spun off from Johnson & Johnson (JNJ) and owns a portfolio of iconic brands: Tylenol, Band-Aid, Listerine, and Neutrogena. This comprehensive index evaluates companies. The chart shows the sector average. It's a benchmark: how does the enduring demand for Kenvue's brands differentiate it from the average competitor?
The AKIM Index for the overall market
Kenvue (KVUE) is a consumer business spun off from Johnson & Johnson. It owns the Band-Aid (bandages), Listerine (mouthwash), and Tylenol (pain reliever) brands. It's a classic defensive sector. This chart, showing the market average, is a backdrop. It helps assess how this stable, predictable business compares to the overall macroeconomic fluctuations that this indicator reflects.